Literature DB >> 832432

NaHCO3 and NaCl tolerance in chronic renal failure II.

F C Husted, K D Nolph.   

Abstract

In patients with chronic renal failure (CRF) (CCr less than 20 ml/min), we have previously demonstrated greater rates of Na excretion (ex) when Na intake was nearly all NaHCO3 as compared to NaCl (both 200 mEq Na daily). Chloride (Cl) wasting on NaHCO3 (with severe Cl restriction) occurred, however, and may in part explain the results. To avoid Cl restriction in 6 patients with CRF (CCr 10-15 ml/min) on an estimated 10 mEq Na and Cl diet, electrolyte ex was compared on NaCl supplements of 200 mEq/day versus a daily mixture of NaHCO3 (100mEq) and NaCl (100 mEq). Periods on NaCl and the mixture lasted 4 days (order randomized) separated by re-equilibration to baseline weight (wt). Mean +/- SEM ex of Na, Cl, HCO3 mEq/day and CCr and deltawt (lbs) are compared below for the 4th day of NaCl vs NaHCO3 intake. (see article). Also there were no significant differences in K excretion, blood pressure, or plasma renin activities. Mean serum HCO3 increased from 21.2 to 25.8 mEq/l (day 1 vs 5, P less than 0.01) reflecting the net positive HCO3 balance on the mixture indicated above. Thus increments of Na intake above a fixed NaCl intake were excreted similarly whether given as NaCl or NaHCO3. Greater Na ex on NaHCO3 may depend on severe Cl restriction and/or higher serum HCO3 levels. If dietary NaCl intakes are near maximum tolerance, NaHCO3 supplementation should be accompanied by reductions in NaCl intake to maintain Na balance,

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 832432

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  11 in total

Review 1.  Current status of bicarbonate in CKD.

Authors:  Mirela Dobre; Mahboob Rahman; Thomas H Hostetter
Journal:  J Am Soc Nephrol       Date:  2014-08-22       Impact factor: 10.121

Review 2.  Metabolic acidosis: pathophysiology, diagnosis and management.

Authors:  Jeffrey A Kraut; Nicolaos E Madias
Journal:  Nat Rev Nephrol       Date:  2010-03-23       Impact factor: 28.314

Review 3.  Short- and long-term effects of alkali therapy in chronic kidney disease: a systematic review.

Authors:  Paweena Susantitaphong; Kamal Sewaralthahab; Ethan M Balk; Bertrand L Jaber; Nicolaos E Madias
Journal:  Am J Nephrol       Date:  2012-05-29       Impact factor: 3.754

Review 4.  Controversial issues in CKD clinical practice: position statement of the CKD-treatment working group of the Italian Society of Nephrology.

Authors:  Vincenzo Bellizzi; Giuseppe Conte; Silvio Borrelli; Adamasco Cupisti; Luca De Nicola; Biagio R Di Iorio; Gianfranca Cabiddu; Marcora Mandreoli; Ernesto Paoletti; Giorgina B Piccoli; Giuseppe Quintaliani; Maura Ravera; Domenico Santoro; Serena Torraca; Roberto Minutolo
Journal:  J Nephrol       Date:  2016-08-27       Impact factor: 3.902

Review 5.  Consequences and therapy of the metabolic acidosis of chronic kidney disease.

Authors:  Jeffrey A Kraut; Nicolaos E Madias
Journal:  Pediatr Nephrol       Date:  2010-06-05       Impact factor: 3.714

Review 6.  Treatment of metabolic acidosis in patients with CKD.

Authors:  Wei Chen; Matthew K Abramowitz
Journal:  Am J Kidney Dis       Date:  2013-08-07       Impact factor: 8.860

7.  Chapter 3: Management of progression and complications of CKD.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2013-01

8.  Chapter 5: Referral to specialists and models of care.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2013-01

9.  Diagnosing metabolic acidosis in chronic kidney disease: importance of blood pH and serum anion gap.

Authors:  Jun-Ya Kaimori; Yusuke Sakaguchi; Sachio Kajimoto; Yuta Asahina; Tatsufumi Oka; Koki Hattori; Yohei Doi; Yoshitaka Isaka
Journal:  Kidney Res Clin Pract       Date:  2022-01-10

10.  Low Serum Bicarbonate Predicts Residual Renal Function Loss in Peritoneal Dialysis Patients.

Authors:  Tae Ik Chang; Ea Wha Kang; Hyung Woo Kim; Geun Woo Ryu; Cheol Ho Park; Jung Tak Park; Tae-Hyun Yoo; Sug Kyun Shin; Shin-Wook Kang; Kyu Hun Choi; Dae Suk Han; Seung Hyeok Han
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.